MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Airtight container and protect from light.

Provenance

Compatibility information derived from Napp and Advanz Pharma products.

Stability Notes

Airtight container and protect from light.

Provenance

Compatibility information derived from Napp and Advanz Pharma products.

Stability Notes

No special precautions for storage required.

Provenance

This compatibility recommendation is derived from Mucodyne 375mg capsules (Sanofi) and Carbocisteine 375mg capsules (Accord Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Multaq 400mg tablets (Sanofi).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Multaq 400mg tablets (Sanofi).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Multaq 400mg tablets (Sanofi).

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatibility recommendation derived from Napp Pharmaceuticals product.

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatibility recommendation derived from Napp Pharmaceuticals product.

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatability recommendation derived from Ethypharm and Napp Pharmaceuticals products.

Stability Notes

Protect from light. Airtight container.

Provenance

Compatibility recommendation derived from Etypharm and Napp Pharmaceuticals products.

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatibility recommendation derived from Etypharm and Napp Pharmaceuticals products.

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.